CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-02 | Howton David T Chief Operating Officer | Option exercise · Restricted Stock Units 10b5-1 | −13,051 | 13,052 | ||
| 2025-12-02 | Cumbo Alexander President and CEO | Option exercise 10b5-1 | +28,612 | 92,196 | ||
| 2025-12-02 | Cumbo Alexander President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −28,612 | 28,613 | ||
| 2025-12-02 | Hanrahan Jessie Chief Regulatory Officer | Option exercise 10b5-1 | +11,862 | 31,143 | ||
| 2025-12-02 | Hanrahan Jessie Chief Regulatory Officer | Option exercise · Restricted Stock Units 10b5-1 | −11,862 | 11,863 | ||
| 2025-12-02 | Herzich Paul Chief Technology Officer | Option exercise 10b5-1 | +7,239 | 29,323 | ||
| 2025-12-02 | Herzich Paul Chief Technology Officer | Option exercise · Restricted Stock Units 10b5-1 | −7,239 | 7,239 | ||
| 2025-11-10 | Ganot Ilan Director | Sale | −3,278 | $4.12 | $14K | 95,412 |
| 2025-10-20 | Brooks Gabriel Chief Medical Officer | Sale | −2,895 | $5.96 | $17K | 33,819 |
| 2025-10-18 | Brooks Gabriel Chief Medical Officer | Option exercise | +9,750 | 36,714 | ||
| 2025-10-18 | Brooks Gabriel Chief Medical Officer | Option exercise · Restricted Stock Units | −9,750 | 19,500 | ||
| 2025-10-06 | SMITH IAN F Director | Option exercise | +4,573 | 126,692 | ||
| 2025-10-06 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −4,573 | 4,573 | ||
| 2025-08-14 | Ganot Ilan Director | Grant or award · Employee Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2025-08-14 | Ganot Ilan Director | Grant or award · Restricted Stock Units | +18,750 | 18,750 | ||
| 2025-08-14 | Howton David T Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-08-14 | Howton David T Chief Operating Officer | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2025-08-14 | Tan Kevin CFO & Treasurer | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-08-14 | Tan Kevin CFO & Treasurer | Grant or award · Restricted Stock Units | +62,500 | 62,500 | ||
| 2025-08-14 | Herzich Paul Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 7 of 12 · 223 trades